WinSanTor

Manufacturing · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

7220 Trade St Ste 370, San Diego, Califo...

Phone Number

(858) 208-0546

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About WinSanTor

WinSanTor is a clinical-stage biotechnology company dedicated to developing treatments for various types of peripheral neuropathies, including those caused by diabetes, chemotherapy, and HIV. The company aims to create the first disease-modifying treatment for neuropathy, focusing on nerve growth and regeneration. With over $40 million in government grants, WinSanTor is advancing its innovative therapies from the lab to patients globally. Their target clients include individuals suffering from neuropathy, particularly diabetics, cancer patients, and the aging population.Explore more
WinSanTor's Social MediaPopular SearchesWinsantor IncWinSanTorWinsan IncWinsan Dist. IncSIC Code 28,283NAICS Code 32,325Show more

WinSanTor Org Chart

SK
United States flag for contact location.

Chief Executive Officer & Co-Founder

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
MJ
United States flag for contact location.

Administrator

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is WinSanTor your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to WinSanTor

Compare insights from companies similar to WinSanTor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

WinSanTor

<$5M
11-50
Private
-
2011
SK
Stanley KimCEO & Co-Founder
$20M
11-50
Private
$51.5M
2015
JH
Jin-Xing HuangScientist III
$8.9M
51-200
Private
-
2007
JK
Joy KissExecutive Director
<$5M
11-50
Private
<$5M
2010
<$5M
1-10
Private
-
-
RV
Ramses VegaPresident and PI
<$5M
11-50
Public
$35M
1987
Christopher Schaber, Chief Executive Officer & Chairman, President at Soligenix
Christopher SchaberCEO & Chairman, President
11-50
Public
-
2018
Tom Lin, Chairman & Chief Executive Officer at Belite Bio
Tom LinChairman & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

WinSanTor is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

WinSanTor is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about WinSanTor.

WinSanTor Tech Stack

A closer look at the technologies used by WinSanTor

WinSanTor News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding WinSanTor

What is WinSanTor's official website?
WinSanTor's official website is www.winsantor.com
What is WinSanTor's Revenue?
WinSanTor's revenue is <$5 Million
What is WinSanTor's SIC code?
WinSanTor's SIC: 28,283
What is WinSanTor's NAICS code?
WinSanTor's NAICS: 32,325
How many employees does WinSanTor have?
WinSanTor has 11-50 employees
What industry does WinSanTor belong to?
WinSanTor is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is WinSanTor competition?
WinSanTor top competitors include: Palmtree Clinical Research, ABRI, Reliant Medical Research, Soligenix
What technology does WinSanTor use?
Some of the popular technologies that WinSanTor uses are: Google Cloud Web Serving, Google Cloud Platform, Microsoft 365, Sectigo
How do I contact WinSanTor?
WinSanTor contact info: Phone number: (858) 208-0546 Website: www.winsantor.com
What does WinSanTor do?

WinSanTor is a clinical-stage biotechnology company dedicated to developing treatments for various types of peripheral neuropathies, including those caused by diabetes, chemotherapy, and HIV. The company aims to create the first disease-modifying treatment for neuropathy, focusing on nerve growth and regeneration. With over $40 million in governmen... t grants, WinSanTor is advancing its innovative therapies from the lab to patients globally. Their target clients include individuals suffering from neuropathy, particularly diabetics, cancer patients, and the aging population.Read More

What are WinSanTor social media links?
WinSanTor Linkedin page WinSanTor Twitter page WinSanTor Facebook page
Is WinSanTor a public company?
WinSanTor is private company therefore does not currently have an official ticker symbol
See more information about WinSanTor

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.